Sunday 4 July 2021

Gentamicin Sulfate Injection Assay (By HPLC) Finished Product | Test Procedure | Method of analysis (MOA) |



 Gentamicin Sulfate Injection Assay (MOA) By HPLC


Mobile phase: 0.025M sodium heptanesulfonate monohydrate in a mixture of 5 volumes of glacial acetic acid, 25 volumes of water and 70 volumes of methanol.

 

Chromatographic Condition

Column        - C18 (12.5 cm × 4.6 mm) (5 µm)

Flow Rate      - 1.5 ml/minute

Temperature  - Ambient column temperature

Detection wavelength -  330 nm

Injection Volume         - 20 µL of each

 

Solution (1): Add 5 ml of methanol to 10 ml of a solution prepared by diluting a suitable volume of the injection with water to contain the equivalent of 0.045% w/v of gentamicin. Swirl and add 4 ml of phthalaldehyde reagent, mix and add sufficient methanol to produce 25 ml, heat in a water bath at 60° for 15 minutes and cool. If the solution is not used immediately, cool to 0° and use within 4 hours.

 

Solution (2): Prepare in the same manner as solution (1) but using 10 ml of a 0.065% w/v solution of(2) gentamicin sulfate WS in place of 10 ml of the preparation being examined.

 

The retention time of component C2 is 10 to 20 minutes. The retention times relative to component C2 are: about 0.13 (reagent); about 0.27 (component C1); about 0.65 (component C1a); about 0.85 (component C2a).

 

System Suitability

The test is not valid unless, in the chromatogram obtained with solution (2), the resolution factor between the peaks due to components C2a and C2 is at least 1.3.